Suppr超能文献

一种从高密度微团培养物中分离出有活力的、软骨分化的人间充质干细胞的可靠方案。

A reliable protocol for the isolation of viable, chondrogenically differentiated human mesenchymal stem cells from high-density pellet cultures.

作者信息

Ullah Mujib, Hamouda Houda, Stich Stefan, Sittinger Michael, Ringe Jochen

机构信息

Tissue Engineering Laboratory and Berlin-Brandenburg Center for Regenerative Therapies, Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin , Berlin, Germany .

出版信息

Biores Open Access. 2012 Dec;1(6):297-305. doi: 10.1089/biores.2012.0279.

Abstract

Administration of chondrogenically differentiated mesenchymal stem cells (MSC) is discussed as a promising approach for the regenerative treatment of injured or diseased cartilage. The high-density pellet culture is the standard culture for chondrogenic differentiation, but cells in pellets secrete extracellular matrix (ECM) that they become entrapped in. Protocols for cell isolation from pellets often result in cell damage and dedifferentiation towards less differentiated MSC. Therefore, our aim was to develop a reliable protocol for the isolation of viable, chondrogenically differentiated MSC from high-density pellet cultures. Human bone marrow MSC were chondrogenically stimulated with transforming growth factor-β3, and the cartilaginous structure of the pellets was verified by alcian blue staining of cartilage proteoglycans, antibody staining of cartilage collagen type II, and quantitative real-time reverse-transcription polymerase chain reaction of the marker genes COL2A1 and SOX9. Trypsin and collagenases II and P were tested alone or in combination, and for different concentrations and times, to find a protocol for optimized pellet digestion. Whereas trypsin was not able to release viable cells, 90-min digestion with 300 U of collagenase II, 20 U of collagenase P, and 2 mM CaCl2 worked quite well and resulted in about 2.5×10(5) cells/pellet. The protocol was further optimized for the separation of released cells and ECM from each other. Cells were alcian blue and collagen type II positive and expressed COL2A1 and SOX9, verifying a chondrogenic character. However, they had different morphological shapes. The ECM was also uniformly alcian blue and collagen type II positive but showed different organizational and structural forms. To conclude, our protocol allows the reliable isolation of a defined number of viable, chondrogenically differentiated MSC from high-density pellet cultures. Such cells, as well as the ECM components, are of interest as research tools and for cartilage tissue engineering.

摘要

软骨分化的间充质干细胞(MSC)给药被认为是一种有前景的方法,用于对受损或患病软骨进行再生治疗。高密度微团培养是软骨分化的标准培养方法,但微团中的细胞分泌细胞外基质(ECM),并被困在其中。从微团中分离细胞的方案常常导致细胞损伤以及向分化程度较低的MSC去分化。因此,我们的目标是开发一种可靠的方案,用于从高密度微团培养物中分离有活力的、软骨分化的MSC。用人转化生长因子-β3对人骨髓MSC进行软骨诱导刺激,通过软骨蛋白聚糖的阿尔辛蓝染色、软骨II型胶原的抗体染色以及标记基因COL2A1和SOX9的定量实时逆转录聚合酶链反应,验证微团的软骨结构。单独或联合测试胰蛋白酶、II型和P型胶原酶,以及不同浓度和时间,以找到优化微团消化的方案。虽然胰蛋白酶不能释放有活力的细胞,但用300 U II型胶原酶、20 U P型胶原酶和2 mM氯化钙消化90分钟效果良好,每个微团可得到约2.5×10(5)个细胞。该方案进一步优化用于分离释放的细胞和ECM。细胞阿尔辛蓝和II型胶原呈阳性,并表达COL2A1和SOX9,证实具有软骨分化特征。然而,它们具有不同的形态。ECM也均匀地呈阿尔辛蓝和II型胶原阳性,但显示出不同的组织和结构形式。总之,我们的方案允许从高密度微团培养物中可靠地分离出一定数量的有活力的、软骨分化的MSC。这些细胞以及ECM成分作为研究工具和用于软骨组织工程具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd06/3559221/64ecfc4ee690/fig-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验